Jämför metoder
Granska de valda metoderna sida vid sida; rader som skiljer sig är markerade.
| Disability Rating Scale× | Påverkan på delaktighet och autonomi× | |
|---|---|---|
| Ämnesområde | Rehabiliteringsvetenskap | Rehabiliteringsvetenskap |
| Familj | Process / pipeline | Process / pipeline |
| Ursprungsår≠ | 1982 | 2001 |
| Upphovsperson≠ | Rappaport, Hall, Hopkins, Belleza, Cope | Cardol, de Haan, de Groot, de Jong |
| Typ≠ | Clinician-rated | Self-report or Proxy |
| Ursprungskälla≠ | Rappaport, M., Hall, K. M., Hopkins, K., Belleza, T., & Cope, D. N. (1982). Disability rating scale for severe head trauma: Relation to rehabilitation outcomes. Archives of Physical Medicine and Rehabilitation, 63(3), 118–123. link ↗ | Cardol, M., de Haan, R. J., de Jong, B. A., van den Bos, G. A., & de Groot, I. J. (2001). Psychometric properties of the Impact on Participation and Autonomy questionnaire. Archives of Physical Medicine and Rehabilitation, 82(2), 210–216. link ↗ |
| Alias | DRS, Rappaport DRS | IPA, IPA-Scale |
| Närliggande | 5 | 5 |
| Sammanfattning≠ | The Disability Rating Scale (DRS) is a brief, clinician-administered measure specifically designed to assess the severity of disability and functional recovery across the entire spectrum of traumatic brain injury (TBI)—from acute coma to community reintegration. Developed by Rappaport and colleagues in 1982, DRS has become a standard outcome measure in TBI research and clinical practice, uniquely spanning acute (comatose) phases through chronic community outcomes where other measures fail. | The Impact on Participation and Autonomy (IPA) scale is a validated, patient-centered measure designed to quantify how chronic conditions or disabilities affect an individual's autonomy and participation in five key life domains: autonomy, mobility, occupation, social relations, and recreation. Developed in the Netherlands by Cardol and colleagues, it operationalizes the WHO handicap concept (now called 'participation restriction') and is widely used in rehabilitation, chronic disease management, and policy evaluation across Europe. |
| ScholarGateDatamängd ↗ |
|
|